Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department

Abstract Interstitial lung disease (ILD), particularly idiopathic pulmonary fibrosis (IPF), has a poor prognosis. Corticosteroids are widely used in the treatment of acute exacerbation of ILD (AE-ILD). This study aimed to clarify the causes of AE-ILD, determine the efficacy of corticosteroids for tr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hye Jin Jang, Seung Hyun Yong, Ah Young Leem, Su Hwan Lee, Song Yee Kim, Sang Hoon Lee, Eun Young Kim, Kyung Soo Chung, Ji Ye Jung, Young Ae Kang, Young Sam Kim, Joon Chang, Moo Suk Park
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5598ecce509f4b1dbc8d4cf2f9ffc59c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5598ecce509f4b1dbc8d4cf2f9ffc59c
record_format dspace
spelling oai:doaj.org-article:5598ecce509f4b1dbc8d4cf2f9ffc59c2021-12-02T13:19:22ZCorticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department10.1038/s41598-021-85539-12045-2322https://doaj.org/article/5598ecce509f4b1dbc8d4cf2f9ffc59c2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85539-1https://doaj.org/toc/2045-2322Abstract Interstitial lung disease (ILD), particularly idiopathic pulmonary fibrosis (IPF), has a poor prognosis. Corticosteroids are widely used in the treatment of acute exacerbation of ILD (AE-ILD). This study aimed to clarify the causes of AE-ILD, determine the efficacy of corticosteroids for treating AE-ILD, and detect differences in the mortality rate among subgroups of ILD. This was an observational retrospective single-center study. Patients with ILD who presented to the emergency department with acute respiratory symptoms from January 1, 2016, to December 31, 2018, were included. Patients with AE-ILD were classified into two groups depending on the prednisolone dose: low dose (0 to 1.0 mg/kg) or high dose (> 1.0 mg/kg). Mortality rates between patients with and without IPF were compared. This study included 182 patients with AE-ILD, including IPF (n = 117) and non-IPF (n = 65). Multivariate Cox regression analysis showed that corticosteroid dose (HR: 0.221, CI: 0.102–0.408, P < 0.001), initial P/F ratio (HR:0.995, CI:0.992–0.999, P = 0.006), and mechanical ventilation within 3 days of hospitalization (HR:4.205, CI:2.059–8.589, P < 0.001) were independent risk factors for mortality in patients with AE-ILD. This study showed that outcomes improve with higher doses of corticosteroids (> 1 mg/kg prednisolone) in patients with AE-non-IPF-ILD. However, this was not the case in patients with AE-IPF.Hye Jin JangSeung Hyun YongAh Young LeemSu Hwan LeeSong Yee KimSang Hoon LeeEun Young KimKyung Soo ChungJi Ye JungYoung Ae KangYoung Sam KimJoon ChangMoo Suk ParkNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hye Jin Jang
Seung Hyun Yong
Ah Young Leem
Su Hwan Lee
Song Yee Kim
Sang Hoon Lee
Eun Young Kim
Kyung Soo Chung
Ji Ye Jung
Young Ae Kang
Young Sam Kim
Joon Chang
Moo Suk Park
Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
description Abstract Interstitial lung disease (ILD), particularly idiopathic pulmonary fibrosis (IPF), has a poor prognosis. Corticosteroids are widely used in the treatment of acute exacerbation of ILD (AE-ILD). This study aimed to clarify the causes of AE-ILD, determine the efficacy of corticosteroids for treating AE-ILD, and detect differences in the mortality rate among subgroups of ILD. This was an observational retrospective single-center study. Patients with ILD who presented to the emergency department with acute respiratory symptoms from January 1, 2016, to December 31, 2018, were included. Patients with AE-ILD were classified into two groups depending on the prednisolone dose: low dose (0 to 1.0 mg/kg) or high dose (> 1.0 mg/kg). Mortality rates between patients with and without IPF were compared. This study included 182 patients with AE-ILD, including IPF (n = 117) and non-IPF (n = 65). Multivariate Cox regression analysis showed that corticosteroid dose (HR: 0.221, CI: 0.102–0.408, P < 0.001), initial P/F ratio (HR:0.995, CI:0.992–0.999, P = 0.006), and mechanical ventilation within 3 days of hospitalization (HR:4.205, CI:2.059–8.589, P < 0.001) were independent risk factors for mortality in patients with AE-ILD. This study showed that outcomes improve with higher doses of corticosteroids (> 1 mg/kg prednisolone) in patients with AE-non-IPF-ILD. However, this was not the case in patients with AE-IPF.
format article
author Hye Jin Jang
Seung Hyun Yong
Ah Young Leem
Su Hwan Lee
Song Yee Kim
Sang Hoon Lee
Eun Young Kim
Kyung Soo Chung
Ji Ye Jung
Young Ae Kang
Young Sam Kim
Joon Chang
Moo Suk Park
author_facet Hye Jin Jang
Seung Hyun Yong
Ah Young Leem
Su Hwan Lee
Song Yee Kim
Sang Hoon Lee
Eun Young Kim
Kyung Soo Chung
Ji Ye Jung
Young Ae Kang
Young Sam Kim
Joon Chang
Moo Suk Park
author_sort Hye Jin Jang
title Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
title_short Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
title_full Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
title_fullStr Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
title_full_unstemmed Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
title_sort corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5598ecce509f4b1dbc8d4cf2f9ffc59c
work_keys_str_mv AT hyejinjang corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT seunghyunyong corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT ahyoungleem corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT suhwanlee corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT songyeekim corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT sanghoonlee corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT eunyoungkim corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT kyungsoochung corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT jiyejung corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT youngaekang corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT youngsamkim corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT joonchang corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
AT moosukpark corticosteroidresponsivenessinpatientswithacuteexacerbationofinterstitiallungdiseaseadmittedtotheemergencydepartment
_version_ 1718393272032821248